The Telegraft is the leading global cell therapy newsletter. It is provided as a benefit of ISCT membership online. It is also used as a promotional vehicle for ISCT activities. This bi-monthly e-newsletter includes insightful discussions and up-to-date information on critical issues affecting the field of cellular therapy.
The Telegraft provides those in or interested in the cell therapy community with current information on new developments, items of interest, regulatory updates, and regular columns on related meetings, organizations and events, summaries of work being done in both academic and industry labs around the world, and much more. Special issues are also published as required to cover developments of particular importance or interest to the membership.
For the 2022 Telegraft Submission Deadline and Release Schedule, as well as for information on how to submit articles and article suggestions to Telegraft , please view below: